Brauneck, F.; Seubert, E.; Wellbrock, J.; Schulze zur Wiesch, J.; Duan, Y.; Magnus, T.; Bokemeyer, C.; Koch-Nolte, F.; Menzel, S.; Fiedler, W.
Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML. Int. J. Mol. Sci. 2021, 22, 12919.
https://doi.org/10.3390/ijms222312919
AMA Style
Brauneck F, Seubert E, Wellbrock J, Schulze zur Wiesch J, Duan Y, Magnus T, Bokemeyer C, Koch-Nolte F, Menzel S, Fiedler W.
Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML. International Journal of Molecular Sciences. 2021; 22(23):12919.
https://doi.org/10.3390/ijms222312919
Chicago/Turabian Style
Brauneck, Franziska, Elisa Seubert, Jasmin Wellbrock, Julian Schulze zur Wiesch, Yinghui Duan, Tim Magnus, Carsten Bokemeyer, Friedrich Koch-Nolte, Stephan Menzel, and Walter Fiedler.
2021. "Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML" International Journal of Molecular Sciences 22, no. 23: 12919.
https://doi.org/10.3390/ijms222312919
APA Style
Brauneck, F., Seubert, E., Wellbrock, J., Schulze zur Wiesch, J., Duan, Y., Magnus, T., Bokemeyer, C., Koch-Nolte, F., Menzel, S., & Fiedler, W.
(2021). Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML. International Journal of Molecular Sciences, 22(23), 12919.
https://doi.org/10.3390/ijms222312919